Gustatory hallucination

Gustatory hallucination is the perception of a taste — bitter, sweet, metallic, or chemical — with no source in anything currently in the mouth.

As a drug effect it is acute and high-dose-dependent, fading as the substance wears off; it is distinct from persistent taste disorders of neurological origin. It ranges from a faint phantom sweetness to vivid, insistent flavors that fully displace any sense of what the mouth actually contains.

Gustatory hallucinations are among the rarer perceptual effects across psychoactive substances. They are most commonly induced at high doses under psychedelics such as 25B-NBOH, 25C-NBOH, and 25C-NBOMe, and under deliriants such as Diphenhydramine, Datura, and Benzydamine. They also appear under depressants such as Eszopiclone, Zolpidem, and Zopiclone, and occasionally under dissociatives such as Ketamine and Dextromethorphan.

Gustatory hallucination is felt as an intrusive taste arriving without physical trigger: a metallic edge, a chemical bitterness, an unexpected sweetness or sourness that seems to originate from inside the mouth itself.

It commonly comes with a heightened awareness of the tongue and throat, and may accompany distortions in other senses. Attending to it tends to sharpen it. At higher doses, particularly under deliriants, it can become fully convincing — indistinguishable in texture and intensity from an actual flavor.

Gustatory hallucination arises through different pathways depending on the drug class:

• Psychedelics — act on 5-HT2A receptors, loosening sensory gating and allowing internally generated taste signals to surface as perceptions.
• Deliriants — block muscarinic acetylcholine receptors broadly, disrupting the normal suppression of spontaneous sensory activity and producing frank hallucinations across modalities, including taste.
• Depressants — non-benzodiazepine hypnotics in particular can generate isolated taste percepts, likely through disruption of thalamocortical signaling during sleep-adjacent states.
• Dissociatives — block NMDA receptors, altering sensory integration in ways that occasionally permit gustatory percepts to emerge.

How much each pathway contributes in a given case is not fully understood.

Who experiences it, and how strongly, varies widely. It is rare even at high doses, but likelihood rises with dose and is highest when other perceptual effects are already prominent.

Set and setting play a role — particularly under psychedelics and deliriants — as does a disposition toward unusual sensory experience and prior history of drug-induced hallucinations. Expectation has less influence here than with mood effects; it tends to appear spontaneously rather than in response to anticipation. Prior familiarity with a substance does not reliably reduce it.